Literature DB >> 25769204

Nasopharyngeal carcinoma: a review.

Fredrik Petersson1.   

Abstract

Nasopharyngeal carcinoma is an umbrella term for a group of malignant epithelial tumors with different etiopathogenesis and a broad range of histopathological appearances. Some types have a dramatically skewed geographical and ethnic distribution and shows virtually 100% association with Epstein Barr virus. The field of other/contributing etiological factors are only partially known and recently a subset of this carcinoma has been linked to transcriptionally active Human Papilloma virus. As with all malignant tumors, the clinical stage of disease is of paramount importance. Despite loco-regionally advanced disease, a large proportion of these patients respond well to radiotherapy, either alone or in combination with chemotherapy and long term sequelae including, but not limited to, development of secondary, radiation-induced malignant tumors is a real clinical problem. This review attempts to provide the practicing pathologist with an overview of nasopharyngeal carcinoma and recent advances in the multifaceted understanding of this group of neoplasms. In addition, some information on prognosis, staging, treatment and treatment related complications in this group of patients is provided.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinoma; Nasopharyngeal carcinoma; Nasopharynx; Pathology

Mesh:

Year:  2015        PMID: 25769204     DOI: 10.1053/j.semdp.2015.02.021

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  64 in total

1.  miR-543 promoted the cell proliferation and invasion of nasopharyngeal carcinoma by targeting the JAM-A.

Authors:  Xue Jiang; Baoqiang Dai; Lichun Feng
Journal:  Hum Cell       Date:  2019-08-19       Impact factor: 4.174

2.  Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Case with Complete Clinical and Radiological Response After Combined Chemoradiotherapy.

Authors:  Jason K Wasserman; Sylvia Papp; Andrew J Hope; Bayardo Perez-Ordóñez
Journal:  Head Neck Pathol       Date:  2018-01-04

3.  Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx.

Authors:  Edward B Stelow; Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2017-02-28

4.  Triterpenoids from Ganoderma lucidum inhibit the activation of EBV antigens as telomerase inhibitors.

Authors:  Dong-Shu Zheng; Liang-Shu Chen
Journal:  Exp Ther Med       Date:  2017-08-03       Impact factor: 2.447

5.  Abnormally expressed microRNA as auxiliary biomarkers for nasopharyngeal carcinoma: A meta-analysis.

Authors:  Zhenzhou Xiao; Wei Peng; Xusheng Zhou; Xiaoli Luo; Yan Chen; Zhaolei Cui
Journal:  Biomed Rep       Date:  2017-11-29

6.  Pre-treatment serum inflammatory cytokines as survival predictors of patients with nasopharyngeal carcinoma receiving chemoradiotherapy.

Authors:  Adel F Al-Kholy; Omminea A Abdullah; Mamdouh Z Abadier; Manal M Hassaan; Mohamed F Shindy; Dalia M Nor El-Dien; Ali Hasaneen
Journal:  Mol Clin Oncol       Date:  2016-09-30

7.  Non-Keratinizing Nasopharyngeal Carcinoma with Adenomatous Differentiation.

Authors:  Fredrik Petersson
Journal:  Head Neck Pathol       Date:  2018-12-06

8.  Reticulocalbin-1 knockdown increases the sensitivity of cells to Adriamycin in nasopharyngeal carcinoma and promotes endoplasmic reticulum stress-induced cell apoptosis.

Authors:  Ze-Hao Huang; Jun Qiao; Yi-Yang Feng; Meng-Ting Qiu; Ting Cheng; Jia Wang; Chao-Feng Zheng; Zhi-Qin Lv; Cai-Hong Wang
Journal:  Cell Cycle       Date:  2020-05-21       Impact factor: 4.534

Review 9.  Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.

Authors:  Deilson Elgui de Oliveira; Bárbara G Müller-Coan; Joseph S Pagano
Journal:  Trends Microbiol       Date:  2016-04-07       Impact factor: 17.079

10.  Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma.

Authors:  Jeremy Setton; James Han; Danita Kannarunimit; Yen-Ruh Wuu; Stephen A Rosenberg; Carl DeSelm; Suzanne L Wolden; C Jillian Tsai; Sean M McBride; Nadeem Riaz; Nancy Y Lee
Journal:  Oral Oncol       Date:  2015-12-07       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.